Acumen Pharmaceuticals Inc

NASDAQ:ABOS   1:13:32 PM EDT
3.52
+0.07 (+2.03%)
Earnings Announcements

Acumen Pharmaceuticals Reports Financial Results For Full Year Ended December 31

Published: 03/28/2022 20:25 GMT
Acumen Pharmaceuticals Inc (ABOS) - Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business Highlights.
Acumen Pharmaceuticals - $225.9 Million in Cash, Cash Equivalents and Marketable Securities at Dec 31, 2021, Expected to Provide Cash Runway Through 2025.
Acumen Pharmaceuticals Inc - Topline Results From Intercept-ad Now Expected in First Half of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.